We are live on
!
Find out more
MS
Maven Securities Portfolio holdings
AUM
$5.06B
1-Year Est. Return
59.27%
This Fund
S&P 500
This Quarter
Est. Return
+28.57%
1 Year Est. Return
+59.27%
3 Year Est. Return
+134.86%
5 Year Est. Return
+167.17%
10 Year Est. Return
–
AUM
$1.01B
AUM Growth
-$202M
(-17%)
Cap. Flow
+$136M
Cap. Flow
% of AUM
13.49%
Top 10 Holdings %
Top 10 Hldgs %
17.77%
Holding
972
New
385
Increased
62
Reduced
71
Closed
428
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AdaptHealth
AHCO
|
+$14.9M |
| 2 |
CLGX
Corelogic, Inc.
CLGX
|
+$14.2M |
| 3 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$13.5M |
| 4 |
GoodRx Holdings
GDRX
|
+$13.3M |
| 5 |
Sotera Health
SHC
|
+$13.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
IMMU
Immunomedics Inc
IMMU
|
+$32.8M |
| 2 |
Caesars Entertainment
CZR
|
+$22.3M |
| 3 |
MYOK
MyoKardia, Inc. Common Stock
MYOK
|
+$20.7M |
| 4 |
TRIT
Triterras, Inc. Class A Ordinary Shares
TRIT
|
+$15.2M |
| 5 |
BHP
BHP
|
+$15.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 33.12% |
| 2 | Miscellaneous | 18.34% |
| 3 | Technology | 12.7% |
| 4 | Industrials | 10.18% |
| 5 | Financials | 8.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
AdaptHealth
AHCO
$826M
| $30.9M | 3.05% |
815,199
+481,705
| +144% | +$14.9M |
|
2
Adaptive Biotechnologies
ADPT
$3.88B
| $25.6M | 2.53% |
430,616
+55,616
| +15% | +$2.87M |
|
3
Invesco QQQ Trust
QQQ
$490B
| $22.2M | 2.2% |
70,772
-29,168
| -29% | -$8.56M |
|
|
ALXN
4
DELISTED
Alexion Pharmaceuticals
ALXN
| $15.8M | 1.57% |
+101,410
| New | +$13M |
|
|
5
BHP
BHP
$234B
| $15.4M | 1.53% |
262,468
-302,054
| -54% | -$15.1M |
|
|
CLGX
6
DELISTED
Corelogic, Inc.
CLGX
| $14.7M | 1.45% |
+189,483
| New | +$14.2M |
|
7
State Street Financial Select Sector SPDR ETF
XLF
$54.3B
| $14.6M | 1.44% |
495,349
+309,063
| +166% | +$8.27M |
|
|
8
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
$22.1B
| $14.1M | 1.4% |
+175,566
| New | +$13.5M |
|
|
9
Sotera Health
SHC
$5.31B
| $13.6M | 1.34% |
+486,982
| New | +$13.1M |
|
|
10
GoodRx Holdings
GDRX
$1.2B
| $12.9M | 1.27% |
305,000
+290,000
| +1,933% | +$13.3M |
|
|
RP
11
DELISTED
RealPage, Inc.
RP
| $12.7M | 1.25% |
+145,222
| New | +$9.52M |
|
12
Willis Towers Watson
WTW
$30.2B
| $11.5M | 1.14% |
+54,672
| New | +$11.3M |
|
13
Outset Medical
OM
$65.2M
| $10.4M | 1.02% |
11,649
+9,659
| +485% | +$7.44M |
|
14
Crown Holdings
CCK
$12.3B
| $9.77M | 0.97% |
97,500
+75,000
| +333% | +$6.89M |
|
|
WORK
15
DELISTED
Slack Technologies, Inc.
WORK
| $9.54M | 0.94% |
+225,490
| New | +$7.62M |
|
16
Canadian Pacific Kansas City
CP
$80.1B
| $9.53M | 0.94% |
137,500
+87,500
| +175% | +$5.7M |
|
|
DISCK
17
DELISTED
Discovery, Inc. Series C Common Stock
DISCK
| $8.82M | 0.87% |
335,313
+277,656
| +482% | +$6.08M |
|
|
XLNX
18
DELISTED
Xilinx Inc
XLNX
| $8.26M | 0.82% |
+58,141
| New | +$7.56M |
|
|
TXNM
19
TXNM Energy Inc
TXNM
$5.99B
| $8.26M | 0.82% |
+170,000
| New | +$8.2M |
|
20
Shattuck Labs
STTK
$652M
| $7.95M | 0.79% |
+150,000
| New | +$4.82M |
|
|
VRTU
21
DELISTED
Virtusa Corporation
VRTU
| $7.95M | 0.79% |
+155,478
| New | +$7.81M |
|
22
CSX Corp
CSX
$90.8B
| $7.95M | 0.79% |
262,500
+165,000
| +169% | +$4.74M |
|
|
ETWO
23
DELISTED
E2open Parent Holdings
ETWO
| $7.95M | 0.79% |
+721,750
| New | +$7.47M |
|
24
Vertiv
VRT
$112B
| $7.91M | 0.78% |
+421,750
| New | +$7.76M |
|
|
ACH
25
Accendra Health
ACH
$84.6M
| $7.9M | 0.78% |
+284,670
| New | +$7.32M |
|
Similar funds
WAM
GIBU
BGDI
YIH
TSC
YCM
GCM
KACA
Maven Securities's Q4 2020 Portfolio in Review
As of Q4 2020, Maven Securities held 972 positions worth $1.01B, down 17% from $1.21B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Maven Securities deployed $136M of net new capital in Q4 2020, opening 385 new positions and adding to 62 existing holdings. Its largest new stake was Corelogic, Inc.: 189,483 shares worth $14.7M.
By sector, the portfolio is most concentrated in Healthcare at 33% of assets, up from 16% a quarter earlier, followed by Miscellaneous and Technology.
On the sell side, the largest reduction was Triterras, Inc. Class A Ordinary Shares, an estimated $15.2M trimmed.
- Maven Securities's largest Q4 2020 buy was Corelogic, Inc.: 189,483 shares worth $14.7M.
- Maven Securities added most to AdaptHealth in Q4 2020, an estimated $14.9M increase.
- Maven Securities's biggest Q4 2020 reduction was Triterras, Inc. Class A Ordinary Shares, cutting an estimated $15.2M.
- Maven Securities fully exited Immunomedics Inc in Q4 2020, selling an estimated $32.8M.
- Maven Securities's ten largest holdings make up 18% of its $1.01B portfolio in Q4 2020.
- Maven Securities opened 385 new positions and closed 428 in Q4 2020.
- Maven Securities's portfolio value fell 17% quarter-over-quarter to $1.01B.
Based on Maven Securities's 13F filing for Q4 2020, filed 12 Feb 2021.